Literature DB >> 21624963

Predisease: when does it make sense?

Anthony J Viera1.   

Abstract

Screening often leads to finding conditions that are not at the stage or level that would classify them as disease but, at the same time, are not at a stage or level at which people can be declared entirely disease free. These "in-between" states have sometimes been designated as "predisease." Examples include precancerous lesions, increased intraocular pressure ("preglaucoma"), prediabetes, and prehypertension. When the goal of preventing adverse health outcomes is kept in mind, this review poses the idea that "predisease" as a category on which to act makes sense only if the following 3 conditions are met. First, the people designated as having predisease must be far more likely to develop disease than those not so designated. Second, there must be a feasible intervention that, when targeted to people with predisease, effectively reduces the likelihood of developing disease. Third, the benefits of intervening on predisease must outweigh the harms in the population. A systematic review of screening guidelines (published in 2003-2010) for 4 sample conditions (cervical cancer, glaucoma, diabetes, and hypertension) is included to assess whether they address these issues, followed by a discussion of the framework questions as they pertain to each condition.

Entities:  

Mesh:

Year:  2011        PMID: 21624963     DOI: 10.1093/epirev/mxr002

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN: 0193-936X            Impact factor:   6.222


  17 in total

Review 1.  Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Gabriel Gimenez-Perez; Didac Mauricio; Marta Roqué I Figuls; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

Review 2.  Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; David Peick Sonne; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2016-10-17

3.  Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice.

Authors:  Gabriel Lázaro-Muñoz; John M Conley; Arlene M Davis; Marcia Van Riper; Rebecca L Walker; Eric T Juengst
Journal:  Am J Bioeth       Date:  2015       Impact factor: 11.229

Review 4.  Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Jesper Krogh; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2016-04-21

5.  Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Authors:  Angela C Cheung; Nicholas F LaRusso; Gregory J Gores; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

Review 6.  Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: a systematic review.

Authors:  Qing Li; Mathew Reeves; John Owen; Louis G Keith
Journal:  Am J Obstet Gynecol       Date:  2014-07-11       Impact factor: 8.661

Review 7.  Recommendations for returning genomic incidental findings? We need to talk!

Authors:  Wylie Burke; Armand H Matheny Antommaria; Robin Bennett; Jeffrey Botkin; Ellen Wright Clayton; Gail E Henderson; Ingrid A Holm; Gail P Jarvik; Muin J Khoury; Bartha Maria Knoppers; Nancy A Press; Lainie Friedman Ross; Mark A Rothstein; Howard Saal; Wendy R Uhlmann; Benjamin Wilfond; Susan M Wolf; Ron Zimmern
Journal:  Genet Med       Date:  2013-08-01       Impact factor: 8.822

Review 8.  Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; David P Sonne; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-05-10

9.  A syndemic of psychiatric morbidity, substance misuse, violence, and poor physical health among young Scottish men with reduced life expectancy.

Authors:  Jeremy Coid; Yingzhe Zhang; Paul Bebbington; Simone Ullrich; Bianca de Stavola; Kamaldeep Bhui; Alexander C Tsai
Journal:  SSM Popul Health       Date:  2021-06-27

10.  High-normal blood pressure and long-term risk of type 2 diabetes: 35-year prospective population based cohort study of men.

Authors:  Christina Hedén Stahl; Masuma Novak; Georgios Lappas; Lars Wilhelmsen; Lena Björck; Per-Olof Hansson; Annika Rosengren
Journal:  BMC Cardiovasc Disord       Date:  2012-10-15       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.